Sources | Names Used |
---|---|
GDSC1000 | QL-VIII-58 |
PharmacoGx | QL-VIII-58 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FGF23 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | JPH3 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | RIT2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | MED17 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | DDHD2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | AK3 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | OR6V1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | TIMELESS | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | FFAR1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | TMEM39A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |